TG Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

TG Therapeutics announced that CEO Michael S. Weiss will present at the 41st Annual J.P. Morgan Healthcare Conference on January 9, 2023, at 9:45 AM PT. The event is hosted at the Westin St. Francis in San Francisco, CA. A live webcast of the presentation will be available on the Company's website. TG Therapeutics is focused on developing innovative therapies for B-cell diseases, with FDA approval for BRIUMVI™ for relapsing forms of multiple sclerosis.

Presentation scheduled for Monday, January 9, 2023 at 9:45 AM PT

NEW YORK, Jan. 06, 2023 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will present at the 41^st Annual J.P. Morgan Healthcare Conference, being held at the Westin St. Francis, in San Francisco, CA. The presentation is scheduled to take place on Monday, January 9, 2023, at 9:45 AM PT.

A live webcast of this presentation will be available on the Events page, located within the Investors & Media section, of the Company’s website at http://ir.tgtherapeutics.com/events.

ABOUT TG THERAPEUTICS, INC.
TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG has received approval from the U.S. FDA for BRIUMVI™ (ublituximab-xiiy), for the treatment of adult patients with relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. For more information, visit www.tgtherapeutics.com, and follow us on Twitter @TGTherapeutics and on LinkedIn.

CONTACT:

Investor Relations
Email: ir@tgtxinc.com
Telephone: 1.877.575.TGTX (8489), Option 4

Media Relations:
Email: media@tgtxinc.com
Telephone: 1.877.575.TGTX (8489), Option 6

FAQ

When is TG Therapeutics presenting at the J.P. Morgan Healthcare Conference?

TG Therapeutics is presenting on January 9, 2023, at 9:45 AM PT.

Who will present for TG Therapeutics at the conference?

Michael S. Weiss, the Chairman and CEO of TG Therapeutics, will present.

Where is the J.P. Morgan Healthcare Conference being held?

The conference is taking place at the Westin St. Francis in San Francisco, CA.

How can I watch the TG Therapeutics presentation?

The presentation will be available via a live webcast on the Company’s website.

What is BRIUMVI™ approved for?

BRIUMVI™ is approved by the U.S. FDA for treating relapsing forms of multiple sclerosis.